-
1
المؤلفون: T. Cavero Escribano, M. Pamplona Casamayor, F. Guerrero Ramos, J.M. Duarte Ojeda, J. Medina Polo, E. González Monte, A. Rodríguez Antolín, F. De La Rosa Kehrmann, F. Villacampa Aubá, A. Tejido Sánchez, J. Passas Martínez
المصدر: European Urology Supplements. 17:e771
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Urology, Internal medicine, medicine, Anti cd20, medicine.disease, business, Discovery and development of mTOR inhibitors, Post-transplant lymphoproliferative disorder
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f69be7343665622694d291dc002ff197Test
https://doi.org/10.1016/s1569-9056Test(18)31369-1 -
2
المصدر: European Urology Supplements. 15:e1735
مصطلحات موضوعية: Oncology, Long term response, medicine.medical_specialty, Everolimus, business.industry, Urology, Internal medicine, medicine, Single institution, Discovery and development of mTOR inhibitors, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::60c823ccb23f1ad171f69624a3192766Test
https://doi.org/10.1016/s1569-9056Test(16)30498-5 -
3
المصدر: European Urology Supplements. 13:e1144
مصطلحات موضوعية: Oncology, Gynecology, medicine.medical_specialty, Practice patterns, business.industry, Public health insurance, Urology, Discovery and development of mTOR inhibitors, medicine.disease, Renal cell carcinoma, Internal medicine, Medicine, In patient, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ea18de49523f9556513d2863e7b54772Test
https://doi.org/10.1016/s1569-9056Test(14)61124-6 -
4
المؤلفون: Stefan Hinz, Viktor Grünwald, Jonas Busch, A. Magheli, L. Weinkauf, Carsten Kempkensteffen, Manfred Johannsen, Kurt Miller, Steffen Weikert
المصدر: European Urology Supplements. 10:231
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Renal cell carcinoma, Urology, Internal medicine, Receptor tyrosine kinase inhibitor, Medicine, In patient, Session (computer science), business, medicine.disease, Discovery and development of mTOR inhibitors
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::cb72b46a23530a9f222d14a5c5b67480Test
https://doi.org/10.1016/s1569-9056Test(11)60713-6 -
5
المؤلفون: Igor Tsaur, Steffen Wedel, Georg Bartsch, Jasmina Makarević, Axel Haferkamp, Roman A. Blaheta
المصدر: European Urology Supplements. 10:294
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Mechanism (biology), Urology, Internal medicine, Cancer research, medicine, Prostate carcinoma, business, Discovery and development of mTOR inhibitors, On resistance, In vitro
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7948be1fd6c7b2af87c3ab6c769b614eTest
https://doi.org/10.1016/s1569-9056Test(11)60921-4 -
6
المؤلفون: D.S. Kim, S.H. Paick, H.Z. Park, W.K. Lee, E.S. Lee, C.Y. Yoon, Sang Eun Lee, Sung Jin Jeong, Seok-Soo Byun, S.W. Doo, Sung Kyu Hong, M.J. Park
المصدر: European Urology Supplements. 9:221
مصطلحات موضوعية: Antitumor activity, Oncology, medicine.medical_specialty, business.industry, Urology, Discovery and development of mTOR inhibitors, Human prostate, Docetaxel, Internal medicine, Medicine, Cancer cell lines, business, PI3K/AKT/mTOR pathway, Hormone, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b17da781911b47c2e362dc2ebb608b55Test
https://doi.org/10.1016/s1569-9056Test(10)60660-4